You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

iMAtinib

( i-MA-ti-nib )
Funding:
Exceptional Access Program
  • iMAtinib - Metastatic Gastrointestinal Stromal Tumours, with specific criteria
  • iMAtinib - Adults with newly diagnosed Ph+ ALL, with specific criteria
  • iMAtinib - Adjuvant Gastrointestinal Stromal Tumours, with specific criteria
ODB - General Benefit (with Therapeutic Notes)
  • iMAtinib - For treatment of Ph+ CML in chronic phase, blast phase or accelerated phase, with specific criteria
Other Name(s): Gleevec®
Appearance: tablet In various strengths, shapes and sizes

You might also be interested in